Covance Not Cooling...
Health Care: Drugs
Celgene Corporation (CELG: NASDAQ)
$124.91 1.43 | 1.16%
05/17/13 - 04:00 PM ET
4.12M / 3.27M
Vol / Avg. Vol:124.56 / 123.48
Open / Prev. Close:120.35 - 125.05
Today's Range:58.53 - 131.82
52 Wk Range:57.36%
Performance YTD:TheStreet Rating:
Portfolios with CELG
- Portfolio NameUser Type
- Userdennis all star
- Userportfolio 1.1
- UserCraigMcIlquham
- User4 Overvalued Biotechs
- ProRay Dalio - Bridgewater Ass...
- ProBill Miller - Legg Mason Ca...
- ContributorStocks Rising On Unusual Vo...
- UserTest Portfolio
- UserMike Fatah's Mega Stock Por...
- User2012 Allocation
Latest CELG Headlines from TheStreet
- Celgene Corporation (CELG): Today's Featured Health Care Laggard 04.18.13 | 05:04 pm
- The Next Big Thing In Biotech: Large-Cap Earnings
04.18.13 | 09:04 am - 5 Stocks Pushing The Drugs Industry Downward 04.15.13 | 01:04 pm
- Cramer's 6 Stocks in 60 Seconds: UA ADBE FTNT ACAD CELG RLGY (Update 1) 04.11.13 | 05:04 pm
- Health Care Standout Celgene Corporation (CELG) Making Gains Today 04.11.13 | 05:04 pm
- Celgene Corporation Stock Buy Recommendation Reiterated (CELG) 04.11.13 | 10:04 am
- Celgene Reaches New 52-Week High (CELG) 04.10.13 | 11:04 am
- Market Takes Aim at Historic Highs Once Again 04.10.13 | 09:04 am
- Risk Of A Major Stock Correction Is Growing 04.09.13 | 01:04 pm
- Biotech Multiples Are Soaring But M&A Is Dead 04.08.13 | 12:04 pm
Press Releases for CELG
- Celgene Corporation To Webcast At Two Upcoming Investor Conferences And The American Academy Of Dermatology Annual Meeting - Business Wire 02.28.13 | 08:02 am
- Celgene Announces $600 Million Accelerated Share Repurchase Program - Business Wire 02.20.13 | 08:02 am
- Celgene Provides REVLIMID® Regulatory Update - Business Wire 02.11.13 | 07:02 am
- POMALYST(R) Brand Therapy (Photo: Business Wire) - Business Wire 02.08.13 | 03:02 pm
- Celgene Corporation To Webcast At Upcoming Investor Conferences - Business Wire 02.04.13 | 08:02 am
- Celgene Reports Strong Fourth Quarter And Full Year 2012 Operating And Financial Results - Business Wire 01.24.13 | 07:01 am
- The True Effect: Positive Findings - Research Report On Celgene Corporation And Gilead Sciences, Inc. - PR Newswire 01.23.13 | 08:01 am
- ABRAXANE® Plus Gemcitabine Demonstrates Significant Survival Advantage In Phase III Study Of Patients With Advanced Pancreatic Cancer - Business Wire 01.22.13 | 06:01 pm
- Celgene Corporation Announces Financial Outlook And Preliminary 2012 Results - Business Wire 01.07.13 | 11:01 am
- Celgene Corporation To Present At The 31st Annual J.P. Morgan Healthcare Conference - Business Wire 12.21.12 | 08:12 am
Partner Headlines for CELG
- Market Close Report: NASDAQ Composite index closes at 3,465.24 down -6.38 points - NASDAQ 05.16.13 | 08:05 pm
- Stocks Close Lower; Dell Little Changed After Earnings - Investor's Business Daily 05.16.13 | 05:05 pm
- Wall Street Turns Down At The Bell; Celgene Sells Off - Investor's Business Daily 05.16.13 | 04:05 pm
- Stocks Flat In Late Trading, But Cisco Lifts Nasdaq - Investor's Business Daily 05.16.13 | 03:05 pm
- Stocks Little Changed; Qihoo, Ocwen Hit New Highs - Investor's Business Daily 05.16.13 | 01:05 pm
- Top-Rated Big-Cap Stocks Rising With Robust Market - Investor's Business Daily 05.13.13 | 05:05 pm
- Stocks End Mixed In Quiet Trade; Stratasys Leads 3D Rally - Investor's Business Daily 05.13.13 | 04:05 pm
- Short Interest in Vertex Rises, in Celgene Falls - Benzinga 05.11.13 | 10:05 am
- After Hours Most Active for May 10, 2013 : HAL, BAC, GM, SINA, QQQ, LYB, PCG, SYMC, DDD, CELG, INTC, ICON - NASDAQ 05.10.13 | 08:05 pm
- Green Mountain's Big Jump Lends A Boost To IBD 50 - Investor's Business Daily 05.10.13 | 06:05 pm
